Asia-Pacific Excipients Market, By Origin (Organic, Inorganic), Category (Primary Excipients, Secondary Excipients), Products (Polymers, Sugars, Alcohols, Minerals, Gelatin, Others), Chemistry Type (Plant, Animals, Synthetic, Minerals), Chemistry Synthesis (Lactose Monohydrate, Sucralose, Polysorbate, Benzyl Alcohol, Cetosteary Alcohol, Soy Lecithin, Pregelatinized Starch, Others), Functionality (Binders and Adhesives, Disintegrants, Coating Material, Coloring Agents, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidients, Chelating Agents, Antifoaming Agents, Others), Dosage Form (Solid, Semi-Solid, Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, Others), Distribution Channel (Direct Tender, Retail Sales, Others) – Industry Trends and Forecast to 2030.
Asia-Pacific Excipients Market Analysis and Size
Increasing demand for alternative routes of delivery/dosage forms and increasing need for pharmaceutical products across varied therapeutic areas are the major drivers which propelled the demand of the market in the forecast period of 2023 to 2030. Pharmaceutical excipients involve everything in a drug except that of the active pharmaceutical ingredients. These molecules don’t possess any medicinal property and are ultimately used for enhancing the physiological absorption of the drug. Excipients are inert in nature and it allows the drug molecule to apply to patients in the right form. Traditionally the excipients were simple molecules but the innovation in technology and increasing demand for novel drug delivery systems enhanced the excipients complexity as well. Excipients promote the patient’s drug acceptability and boost up the drug stability and its bioavailability. Moreover, excipients help in the maintenance of drug integrity that helps in drug storage.
Data Bridge Market Research analyses that the Asia-Pacific excipients market which was USD 1,143.55 million in 2022, is expected to reach USD 1,932.68 million by 2030, and is expected to undergo a CAGR of 8.2% during the forecast period of 2023 to 2030. “Organic” dominates the origin segment of the Asia-Pacific excipients market owing to the high demand for this type of excipients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Excipients Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Origin (Organic, Inorganic), Category (Primary Excipients, Secondary Excipients), Products (Polymers, Sugars, Alcohols, Minerals, Gelatin, Others), Chemistry Type (Plant, Animals, Synthetic, Minerals), Chemistry Synthesis (Lactose Monohydrate, Sucralose, Polysorbate, Benzyl Alcohol, Cetosteary Alcohol, Soy Lecithin, Pregelatinized Starch, Others), Functionality (Binders and Adhesives, Disintegrants, Coating Material, Coloring Agents, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidients, Chelating Agents, Antifoaming Agents, Others), Dosage Form (Solid, Semi-Solid, Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, Others), Distribution Channel (Direct Tender, Retail Sales, Others)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
Ashland Global Holdings Inc. (U.S.), BASF SE (Germany), Croda International Plc (U.K.), Colorcon Inc. (U.S.), Dow (U.S.), Evonik Industries AG (Germany), FMC Corporation (U.S.), Innophos Holdings Inc. (U.S.), JRS Pharma (Germany), Kerry Group plc (Ireland), Shin-Etsu Chemical Co., Ltd. (Japan), Zhejiang Hengdian Apeloa Imp. & Exp. Co., Ltd. (China), Merck KGaA (Germany)
|
|
Market Opportunities
|
|
Market Definition
Excipients are inactive substances that are added to pharmaceutical products or drugs to serve various purposes. They are an essential component of drug formulations and play a crucial role in ensuring the stability, effectiveness, and safety of the medication. Excipients are typically added in small quantities and do not have any therapeutic effect on their own. It's important to note that the selection of excipients depends on the specific requirements of the drug formulation, dosage form, and intended use. Regulatory bodies, such as the United States Pharmacopeia (USP) and the European Pharmacopoeia (Ph. Eur.), provide guidelines and specifications for the quality and use of excipients in pharmaceutical products.
Asia-Pacific Excipients Market Dynamics
Drivers
- Advancements in Drug Delivery Technologies
The development of novel drug delivery systems, such as controlled-release formulations, transdermal patches, and inhalation systems, requires specific excipients to achieve the desired release profiles and therapeutic outcomes. This drives the demand for specialized excipients tailored for these technologies. The continuous development of new drugs and the need for innovative drug delivery systems require a wide range of excipients to enhance drug stability, solubility, bioavailability, and patient compliance. This drives the demand for diverse and specialized excipients.
- Research and Development Proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the pharmaceutical drugs and various diagnosis methods will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the integration of advanced technologies in the healthcare facilities is also bolstering the market growth rate.
- Growing Investment for Healthcare Facilities
Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.
Opportunities
- Expansion of the Pharmaceutical Industry
The pharmaceuticals industry is experiencing growth due to various factors, including advancements in device development, increasing investments in research and development, and expanding healthcare infrastructure. This growth directly impacts the Asia-Pacific excipients market.
-
Government Investments on Healthcare Infrastructure
The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities. Also, high return on investments assured by the research activities will also work in the favor of the market.
Restraints/Challenges
- Rising Competition
The Asia-Pacific excipients market is highly competitive, with numerous companies offering a wide range of products. This can make it challenging for new entrants or smaller companies to gain market share and establish a strong presence.
-
High Cost associated with Drug Development and Distribution
The cost of drug development and its distribution is very high in the market. Healthcare systems and payers face cost pressures, and there is a growing demand for cost-effective solutions. Manufacturers need to balance the development of innovative implants with affordability to meet market demands.
This Asia-Pacific excipients market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific excipients market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In November 2017, BASF SE has entered into an agreement with DIEM labs, LLC for the distribution of U.S. medical food product. This agreement will expand the product portfolio of the company
Asia-Pacific Excipients Market Scope
The Asia-Pacific excipients market is segmented on the basis of origin, category, products, chemistry type, chemical synthesis, functionality, dosage forms, route of administration, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Origin
- Organic
- Inorganic
Category
- Primary Excipients
- Secondary Excipients
Products
- Polymers
- Sugars
- Alcohols
- Minerals
- Gelatin
- Others
Chemistry Type
- Plant
- Animals
- Synthetic
- Minerals
Chemical Synthesis
- Lactose Monohydrate
- Sucralose
- Polysorbate
- Benzyl Alcohol
- Cetosteary Alcohol
- Soy Lecithin
- Pregelatinized Starch
- Others
Functionality
- Binders and Adhesives
- Disintegrants,
- Coating Material
- Coloring Agents
- Solubilizers
- Flavors
- Sweetening Agents
- Diluents
- Lubricants
- Buffers
- Emulsifying Agents
- Preservatives
- Antioxidants
- Sorbents
- Solvents
- Emollients
- Glidients
- Chelating Agents
- Antifoaming Agents
- Others
Dosage Forms
- Solid
- Semi-Solid
- Liquid
Route of Administration
- Oral Excipients
- Topical Excipients
- Parenteral Excipients
- Other Excipients
End Users
- Pharmaceutical and Biopharmaceutical Companies
- Contract Formulators
- Research Organization and Academics
- Others
Distribution Channel
- Direct Tender
- Retail Sales
- Others
Asia-Pacific Excipients Market Regional Analysis/Insights
The Asia-Pacific excipients market is analysed and market size insights and trends are provided by country, origin, category, products, chemistry type, chemical synthesis, functionality, dosage forms, route of administration, end user and distribution channel as referenced above.
The countries covered in the Asia-Pacific excipients market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
China dominates the Asia-Pacific excipients market because of the strong base of healthcare facilities, strong presence of major players in the market, and rising number of research activities in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Asia-Pacific excipients market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific excipients market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific excipients market. The data is available for historic period 2015-2020.
Competitive Landscape and Asia-Pacific Excipients Market Share Analysis
The Asia-Pacific excipients market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Asia-Pacific excipients market.
Some of the major players operating in the Asia-Pacific excipients market are:
- Ashland Global Holdings Inc. (U.S.)
- BASF SE (Germany)
- Croda International Plc (U.K.)
- Colorcon Inc. (U.S.)
- Dow (U.S.)
- Evonik Industries AG (Germany)
- FMC Corporation (U.S.)
- Innophos Holdings Inc. (U.S.)
- JRS Pharma (Germany)
- Kerry Group plc (Ireland)
- Shin-Etsu Chemical Co., Ltd. (Japan)
- Zhejiang Hengdian Apeloa Imp. & Exp. Co., Ltd. (China)
- Merck KGaA (Germany)
SKU-